The Hepatitis B Vaccine Market size was valued at USD 8.26 billion in 2023 and is estimated to reach USD 11.84 billion in 2031 with an emerging CAGR of 4.6% Over the forecast period of 2024-2031.The Hepatitis B vaccine market is experiencing robust growth driven by heightened awareness of liver diseases and the urgent need for preventative healthcare. Advances in biotechnology have led to...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian